Tradestie Institutional Equity Comparison Engine · Market Close Nov 02, 2026

LVRO vs MLEC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MLEC Captures Overall Composite Edge (40.8 SELL vs 41.1 SELL), While LVRO Leads 5–0 on Growth & Valuation Pillars

MLEC Overall Winner 6-Pillar Tally: LVRO 5 – 0 MLEC (1 Tie) Matrix Metrics: LVRO 6 – 3 MLEC

As of Nov 02, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over Lavoro Limited Class A (LVRO) on higher Unified Composite conviction (40.8/100 SELL vs. 41.1/100 SELL) after splitting the core matrix 3–6 (led by composite factor balance), while LVRO wins 5–0 across the 6-pillar growth and valuation breakdown. LVRO trades at $0.30 (63.7x Forward P/E, 0.2% operating margin) versus MLEC at $0.85 (N/M Forward P/E, 0.0% operating margin).

  • Growth vs. Quality Trade-Off: MLEC earns the overall head-to-head edge with a stronger Unified Composite Score (40.8/100 SELL vs. LVRO 41.1/100 SELL) and 0.05β · 208% Vol risk profile, whereas LVRO leads top-line expansion (-13.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although MLEC compares more favorably head-to-head, both LVRO (41.1/100 SELL) and MLEC (40.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: LVRO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.4); meanwhile MLEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About LVRO vs MLEC
LVRO NASDAQ
Lavoro Limited Class A Ordinary Shares
Retail-Miscellaneous Retail
$0.30
-24.42% 1D
Market Cap $60.8M
TTM Revenue $9.08B
Forward P/E 63.7x
Beta / 30D Vol 1.04β · 160% Vol
Unified Composite Score
41.1 / 100 SELL
Tech 55.0 Fund 46.0 Flow 50.0 Mom 26.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 21
RSI-14: 21.4 · SMA20: $0.94 · SMA50: $0.89
MLEC NASDAQ Head-to-Head Winner
Moolec Science SA Ordinary Shares
Textile Mill Products
$0.85
-39.29% 1D
Market Cap $1.0M
TTM Revenue $7.8M
Forward P/E N/M
Beta / 30D Vol 0.05β · 208% Vol
Unified Composite Score
40.8 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -30.9%), weak momentum, RSI 17
RSI-14: 16.8 · SMA20: $2.06 · SMA50: $4.58

6-Pillar Scorecard Institutional Category Breakdown (LVRO 5 – 0 MLEC)

Columns: Metric · LVRO · MLEC
1. Valuation Multiples LVRO
Forward P/E 63.7x N/M
Trailing P/E 63.7x N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.1x
2. Growth & Scale LVRO
Revenue Growth (YoY) -13.2% +948.3%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $9.08B $7.8M
Market Cap $60.8M $1.0M
3. Profitability & Quality LVRO
Gross Margin 15.0% -8.2%
Operating Margin 0.2% 0.0%
Net Profit Margin -10.4% 0.0%
Return on Equity (ROE) -62.4% -174.7%
4. Balance Sheet & Cash Flow LVRO
Cash Generation (TTM) $106M EBITDA -$8.1M EBITDA
Cash Flow Margin 1.2% EBITDA Mgn -103.1% EBITDA Mgn
Net Cash / Leverage $1.35 Book/Sh · -62.4% ROE $0.70 Book/Sh · -174.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat LVRO
OpEx & R&D Intensity 14.8% of Rev ($1.34B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Agricultural Inputs Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: LVRO (6) vs MLEC (3)
Institutional Metric LVRO MLEC Criterion Row Edge
Market Capitalization
Scale
$60.8M $1.0M Larger Scale LVRO
Trailing P/E Ratio
Valuation
63.7x N/M Lower Multiple LVRO
Forward P/E Ratio
Valuation
63.7x N/M Lower Multiple LVRO
Revenue Growth (YoY)
Growth
-13.2% +948.3% Higher Growth MLEC
Operating Margin (TTM)
Profitability
0.2% 0.0% Higher Margin Tie
Net Profit Margin
Profitability
-10.4% 0.0% Higher Margin MLEC
Return on Equity (ROE)
Capital Efficiency
-62.4% -174.7% Higher ROE LVRO
52-Week Range Position
Momentum
2% ($0–$5) 3% ($0–$23) Stronger Trend MLEC
Beta / 30D Volatility
Risk Regime
1.04β · 160% Vol 0.05β · 208% Vol Lower Realized Risk LVRO
Unified Institutional Score
Composite Signal
41.1 / 100 (SELL) 40.8 / 100 (SELL) Higher Composite LVRO
Trailing 12M Revenue (USD)
Operating Scale
$9.08B $7.8M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
15.0% -8.2% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$106M EBITDA ($1.35 Book/Sh · -62.4% ROE) -$8.1M EBITDA ($0.70 Book/Sh · -174.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MLEC +208.5 pp
LVRO: -72.36% · MLEC: +136.14%
3M Horizon MLEC +2818.5 pp
LVRO: -73.79% · MLEC: +2744.71%
6M Horizon MLEC +2546.56 pp
LVRO: -77.97% · MLEC: +2468.59%
1Y Horizon MLEC +2546.56 pp
LVRO: -77.97% · MLEC: +2468.59%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LVRO vs MLEC. Trailing 12-month operating profitability (LVRO 0.2% vs MLEC 0.0%) and valuation multiples (LVRO 63.7x vs MLEC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

LVRO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$9.08B
Gross Margin15.0%
Op. Margin0.2%
ROE / Fwd P/E-62.4% · 63.7x
MLEC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$7.8M
Gross Margin-8.2%
Op. Margin0.0%
ROE / Fwd P/E-174.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
LVRO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact LVRO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
MLEC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MLEC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
LVRO Moat Profile Cyclical / Execution-Driven Positioning
Agricultural Inputs Operator
Competes within the Agricultural Inputs value chain with $60.8M market capitalization and 0.2% operating margin.
OpEx & R&D Reinvestment 14.8% of Rev ($1.34B)
90D Engineering Disclosures 0 Published
MLEC Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $1.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ LVRO vs MLEC Key Questions & Quantitative Answers

As of Nov 02, 2026, Moolec Science SA (MLEC) captures the overall head-to-head institutional edge over Lavoro Limited Class A (LVRO) on higher Unified Composite conviction (40.8/100 SELL vs. 41.1/100 SELL) after splitting the core matrix 3–6 (led by composite factor balance), while LVRO wins 5–0 across the 6-pillar growth and valuation breakdown. LVRO trades at $0.30 (63.7x Forward P/E, 0.2% operating margin) versus MLEC at $0.85 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: MLEC earns the overall head-to-head edge with a stronger Unified Composite Score (40.8/100 SELL vs. LVRO 41.1/100 SELL) and 0.05β · 208% Vol risk profile, whereas LVRO leads top-line expansion (-13.2% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although MLEC compares more favorably head-to-head, both LVRO (41.1/100 SELL) and MLEC (40.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: LVRO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 21.4); meanwhile MLEC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 16.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

LVRO leads the Growth & Scale pillar: LVRO posts -13.2% YoY revenue growth and +0.0% YoY earnings growth on $9.08B TTM revenue (15.0% gross margin, 0.2% operating margin), compared with MLEC at +948.3% YoY revenue growth and +0.0% YoY earnings growth on $7.8M TTM revenue (-8.2% gross margin, 0.0% operating margin). On trailing 12-month operating scale, LVRO generates $9.08B in USD-normalized revenue versus $7.8M for MLEC. In operating R&D and SG&A reinvestment, LVRO deploys 14.8% of Rev ($1.34B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MLEC.

LVRO screens cheaper on headline valuation multiples. LVRO trades at 63.7x Forward P/E, 63.7x Trailing P/E, N/M PEG, and N/M EV/Revenue (1.2% EBITDA margin), whereas MLEC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-103.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LVRO (-62.4% ROE) versus MLEC (-174.7% ROE) capital efficiency.

In options market volatility and institutional positioning, LVRO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 160% Vol realized risk). By comparison, MLEC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.05β · 208% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 02, 2026. For educational research only; not investment advice.